Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07499037
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Registry
-
NCT07499037
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07499037. Non-randomized; no masking; primary purpose treatment. Start 2027-01 (anticipated); primary completion 2029-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO
- Condition
- Pneumonia
- Condition
- Heart Failure
- Intervention (Drug)
- Low anticoagulation dose of argatroban and enoxaparin during ECMO
- Intervention (Drug)
- Standard anticoagulation dose of argatroban and enoxaparin during ECMO
- Lead sponsor
- University Hospital Ostrava
- Collaborator
- University Hospital, Motol
Record details
- Record id
cardio:ct-nct07499037- Content hash
6ad17e8be3f7161ebc512721cc61920e2852a59c7bd55b513f011672668dc0b4